findmyKOL

Talene Yacoubian

Basic profile

Civitan International

ORCID↗NPI↗
✓ Full record
RegionBirmingham, AL · SoutheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL type: NationalLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2008–2026Why? →

Talene Yacoubian is a Neurology physician affiliated with Civitan International. OpenAlex indexes 75 publications with 2,532 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
75publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,532citations

Total citations across indexed works.

28h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
11NIH grants · 2008–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1717 6th Ave S
Birmingham, AL 352331801

Telephone

800-822-8816

Registry record last updated 28 Jun 2023.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    87.7%
    Aromatic Amino Acid Decarboxylation Inhibitor27.8%
    Carbidopa-Levodopa74%Carbidopa-Levodopa Er26%
    Part D≥62 patients
    Benzodiazepine13.9%
    Clonazepam84%Diazepam16%
    Part D<11 patients

    + 14 more classes in this area

  • Musculoskeletal

    5.3%
    gamma-Aminobutyric Acid-ergic Agonist3.7%
    Baclofen100%
    Part D<11 patients
    Muscle Relaxant1.6%
    Cyclobenzaprine Hcl100%
    Part D<11 patients
  • Cardiovascular

    3.3%
    Beta blocker3.3%
    Propranolol Hcl Er64%Propranolol Hcl36%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

11 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:

All 54 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”